Subscribe to Newsletter

Drug Delivery

Discovery & Development Business Practice

Accelerate liquid formulation development for protein biopharmaceuticals

The work presented here illustrates how Differential Scanning Calorimetry (DSC) is used in the early stages of protein characterization to rapidly provide critical data about protein stability that can be used as a guide to support and accelerate liquid formulation.

Discovery & Development Drug Delivery

Screening, Identifying, and Quantifying Potential Genotoxic Compounds with High Resolution LC/MS

Analysis of chlorhexidine drug substance using an Agilent 6545 Accurate Mass Q-TOF System and MassHunter Mass Profiler Software.

Manufacture Drug Delivery

Aptar Pharma’s Ophthalmic Squeeze Dispenser – Innovation based on experience

| Sponsored by Aptar

Although the discussion about the use of preservatives is still somewhat controversial, clinical evidence suggests that patients benefit from unpreserved eye drops especially in chronic conditions.

Discovery & Development Drug Delivery

Dosing For Compliance

| Sven Stegemann

Are current dosage forms really as easy and convenient for patients as pharma manufacturers say they are?

Discovery & Development Drug Delivery

Three’s a Charm

Nanoparticles help to deliver a three-in-one attack on metastatic melanoma cells

Discovery & Development Drug Delivery

Bio-Butterfingers

Lipoprotein-nanoplatelets leave researchers hungry to explore drug delivery potential

Discovery & Development Drug Delivery

From Brick Dust to Blockbuster?

| Sponsored by BASF

Many drug candidates are as poorly soluble as “brick dust”, making oral delivery a significant challenge.

Discovery & Development Drug Delivery

New Age Traveler

From Iceland’s volcanic springs to a lab in South Denmark; does the microbe Sulfolobus. islandicus hold the key to a drug’s safe transit through the gut?

Manufacture Drug Delivery

Sublingual Vaccines – A Taste of the Future?

| Sponsored by Catalent

What if biologics and vaccines could be delivered via the buccal or sublingual route?

Discovery & Development Business Practice

Measuring Low-Level Polymorphic Contamination using Morphologically Directed Raman Spectroscopy

| Sponsored by Malvern Panalytical

Polymorphic conversions are an ongoing problem in the pharmaceutical industry.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register